The correlation of dopamine transporter imaging to clinical phenotypes, core symptoms and clinical scores in DLB was addressed in 19 studies (32%) [11, 14–16, 18, 32, 33, 35, 40, 41, 44, 48, 58, 60–65]. This evidence concerns the gene SLC6A3 and Lewy body dementia.